Abstract:
The present invention provides compositions and methods of using stereospecific benzodiazepine derivatives, their salts and prodrugs for the treatment of anxiolytic or convulsant disorders having the side effects of reduced alcohol craving in human alcoholics and a concomitant reduced sedative, hypnotic, muscle relaxant and ataxic side-effects. The invention further provides pharmaceutical compositions for treatment of anxiolytic and convulsant disorders in subjects in need thereof, comprising a compound, prodrug or a salt having a chemical structure represented by any one of Formula I-XXI and a pharmaceutically-acceptable carrier.
Abstract:
Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
Abstract:
Orally active benzodiazepine derivatives and their salts are disclosed. These compounds and their salts have anxiolytic and anticonvulsant activity with reduced sedative/hypnotic/muscle relaxant/ataxic effects.
Abstract:
The present invention provides molecules and methods for fluorescent microscopy and visualization of biomolecules, such as cholesterol. In a preferred embodiment, the present invention provides a compound having the structure: wherein R1 and R2 are selected from the group consisting of H, CnH2n+1, (CH2)mNH2, (CH2)mNH—SO2—R′, and CH2CH2OCH2CH2NH2 wherein n has a value between 4 and 18, wherein m has a value between 2 and 8, and wherein R′ is selected from the group consisting of CH3, C6H4, C6H4CH3, C6H4CO2H an its cyclic imide, C6H4Br, anthraquinon-2-yl, and 5-formyl-2-furyl, 2-carboxyphenyl.
Abstract translation:本发明提供用于荧光显微镜和生物分子如胆固醇的可视化的分子和方法。 在优选的实施方案中,本发明提供具有以下结构的化合物:其中R 1和R 2选自H,C n, (CH 2)2 H 2n + 1,(CH 2)2 NH 2,(CH 2) NH 2 SO 2 -R'和CH 2 CH 2 CH 2 O(CH 3) 其中n具有在4和18之间的值,其中m具有在2和8之间的值,并且其中R'被选择 由CH 3,C 6 H 4,C 6 H 4,CH 3,CH 3, CH 3,CH 3,CO 2,C 2,C 6,C 6,C 6, H 4 Br,蒽醌-2-基和5-甲酰基-2-呋喃基,2-羧基苯基。
Abstract:
A method of expressing proteins is disclosed. In a preferable embodiment, the method comprises placing a DNA sequence encoding a protein or peptide and expression vector containing a regulatable promoter expressible in Rhodospirillum rubrum and expressing the protein within a bacterial host, wherein the host has extra capacity for membrane formation and wherein the host is a member of the genus Rhodospirillum.
Abstract:
A composition and method for forming investment casting shells includes using colloidal silica, zircon flour, and fused silica in a slurry which is applied to a pattern. After the slurry is applied to the pattern, it is allowed to partially or completely solidify. After the shell has solidified, the pattern may be melted or otherwise removed. A molten material is introduced into the shell and allowed to cool to form an article. Finally, the shell is broken away or otherwise removed from the article. The improved shell slurry composition and corresponding method minimizes pattern-to-pour cycle times and is environmentally friendly.
Abstract:
Films of gallium manganese nitride are grown on a substrate by molecular beam epitaxy using solid source gallium and manganese and a nitrogen plasma. Hydrogen added to the plasma provides improved uniformity to the film which may be useful in spin-based electronics.
Abstract:
An airborne silica detection system provides a chemiluminescence reaction for quantitative assessment of silica on an automated basis. A prefilter allows reaction to be sensitive to particle sizes relevant to chronic respiratory diseases.
Abstract:
Various embodiments disclosed relate to a method of preparing aryl fluorinated ether compounds. The method involves contacting an aryl halide with a fluorinated alcohol in the presence of a photocatalyst, a base, and irradiation with electromagnetic radiation comprising a wavelength between about 200 nm and about 800 nm. The present invention also provides a method of late-stage photochemical modification of a biologically active compound, such as drugs or agrochemicals. Fluorinated derivatives of griseofulvin, clofibrate, and 2,4-D methyl ester are described herein.